市场调查报告书
商品编码
1470853
内视镜再处理市场:依产品、最终用户划分 - 2024-2030 年全球预测Endoscope Reprocessing Market by Product (Automated Endoscope Reprocessors, Detergents & Wipes, Endoscope Drying, Storage, & Transport Systems), End-User (Ambulatory Surgical Centers & Clinics, Hospitals) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年内视镜再处理市场规模为31.7亿美元,2024年达34.5亿美元,预计2030年将达58.3亿美元,复合年增长率为9.08%。
内视镜再处理是一项重要的灭菌程序,旨在降低使用之间的感染风险。内视镜是一根带有灯和摄影机的柔性管,用于观察人的胃肠道内部。使用后,内视镜必须彻底清洗和消毒,以消除微生物污染。胃肠道疾病、癌症和心血管疾病等需要内视镜检查的疾病的盛行率不断上升,正在推动内视镜再处理市场的成长。随着手术数量的增加,对再加工内视镜的需求也增加。具有增强消毒和清洗能力的现代自动化再处理设备提高了感染控製程序的有效性。此类进步可以轻鬆满足医疗保健环境中对病人安全和卫生日益增长的需求。食品药物管理局(FDA) 和疾病管制中心 (CDC) 等监管机构已将其标准集中在内视镜再处理上,重点关注感染控制和预防。医疗机构严格执行这些法规可确保内视镜再处理的安全和标准化实践,从而推动市场成长。然而,开拓内视镜再处理解决方案的高成本阻碍了市场成长。更多引进技术先进的内视镜再处理解决方案预计将创造市场成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 31.7亿美元 |
预测年份 [2024] | 34.5亿美元 |
预测年份 [2030] | 58.3亿美元 |
复合年增长率(%) | 9.08% |
扩大清洁剂和擦拭巾的使用,以防止产品生物膜积聚并确保全面消毒
自动化内视镜再处理机 (AER) 透过标准化消毒流程、加强感染控制和降低污染风险,彻底改变了内视镜再处理产业。儘管效率不断提高,但仍需要进行详细研究来评估 AER 的采用水准、成本效益和技术进步。清洗和擦拭巾透过防止生物膜累积并确保全面消毒,为内视镜再处理过程提供重要支援。生物相容性、功效和易用性等因素对市场动态的影响需要彻底检验。内视镜干燥、储存和运输系统本质上与减少内视镜再处理相关的感染疾病有关。内视镜追踪解决方案可增强库存管理、提高病患安全并增强资料记录和共用功能。对这些解决方案的详细评估揭示了将推动未来市场趋势的潜在成长领域、客户需求和技术进步。高水准消毒剂和试纸在确保内视镜无菌方面发挥着至关重要的作用。
最终用户:医院更采用内视镜再处理,重点在于有效的感染控制和预防
门诊手术中心和诊所正在使用内视镜再处理来满足对用于患者照护的经济高效的无菌设备不断增长的需求,减少对环境的影响,并遵守严格的卫生法规。随着内视镜设计变得越来越复杂,它们还需要先进的再处理解决方案来进行有效灭菌,这种需求随着患者数量的增加而不断增长。鑑于使用内视镜的医疗科室多种多样,例如泌尿系统、泌尿科和呼吸系统医疗设备,医院的最终用户群涵盖了更广泛的医疗保健提供者。该群体包括参与内视镜处理、使用、清洗和再处理各阶段的内科医生、外科医生、内视镜护理师、麻醉师和设施内务人员。医院对再处理内视镜的需求主要是出于病人安全考虑,因为医院为大量患有多种疾病和合併症的患者提供服务。它也受到对有效感染控制和预防的日益重视以及保持医疗设备无菌的监管要求的影响。医院对微创手术的需求不断增加,导致内视镜的使用增加,这反过来又增加了对有效再处理的需求。在这两种情况下,人们越来越认识到专业再处理内视镜的相关性和好处是一个令人鼓舞的趋势。
区域洞察
由于胃肠道疾病、癌症和其他慢性病等需要内视镜检查的疾病的盛行率不断上升,美洲尤其是北美的内视镜再处理市场呈现持续成长的趋势。微创手术和技术进步的不断成长趋势正在推动美洲内视镜再处理市场的成长。全部区域不断发展的医疗基础设施以及不断增加的旨在早期疾病检测的政府和非营利组织倡议正在推动内视镜检查的需求。然而,成本限制和技术人员缺乏可能会在一定程度上阻碍市场成长。欧洲、中东和非洲地区是内视镜再处理市场的主要参与者,其中欧洲处于领先地位。欧洲成长的背后是人口老化、内视镜手术需求的快速成长以及强大的技术基础。另一方面,中东和非洲市场目前成长相对缓慢,主要是由于医疗保健机会有限和技术采用延迟。儘管如此,由于挖掘潜在市场和增加医疗基础设施投资,仍有成长前景。
FPNV定位矩阵
FPNV定位矩阵对于评估内视镜再处理市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对内视镜再处理市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.内视镜再处理市场的市场规模与预测为何?
2.在内视镜再处理市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.内视镜再处理市场的技术趋势和法规结构是什么?
4.内视镜再处理市场主要厂商的市场占有率为何?
5.进入内视镜后处理市场的合适型态和策略手段是什么?
[192 Pages Report] The Endoscope Reprocessing Market size was estimated at USD 3.17 billion in 2023 and expected to reach USD 3.45 billion in 2024, at a CAGR 9.08% to reach USD 5.83 billion by 2030.
Endoscope reprocessing is an essential sterilization procedure designed to reduce the risk of infection between uses. An endoscope is a flexible tube with a light and camera attached to it, used for viewing the interior of a person's digestive tract. Following use, endoscopes need to be meticulously cleaned and disinfected to eliminate microbial contamination. The rising prevalence of diseases that require endoscopy procedures, such as gastrointestinal ailments, cancer, and cardiovascular diseases, is driving the growth of the endoscope reprocessing market. With an increasing number of procedures performed, there's an elevated demand for reprocessed endoscopes. Modern automatic reprocessors, equipped with enhanced disinfection and cleaning capabilities, reinforce the effectiveness of infection control procedures. Such advancements readily cater to the growing demand in healthcare settings for patient safety and hygiene. Regulatory organizations, such as the Food and Drug Administration (FDA) and Center for Disease Control (CDC), centralize their standards on endoscope reprocessing around infection control and prevention. The strict implementation of these regulations across healthcare institutions guarantees the safe and standardized practice of endoscope reprocessing, thereby driving market growth. However, the high cost associated with the development of endoscope reprocessing solutions is hindering market growth. The rising introduction of technologically advanced endoscope reprocessing solutions is expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.17 billion |
Estimated Year [2024] | USD 3.45 billion |
Forecast Year [2030] | USD 5.83 billion |
CAGR (%) | 9.08% |
Product: Growing usage of detergents & wipes for preventing biofilm build-up and ensuring comprehensive disinfection
Automated endoscope reprocessors (AERs) have revolutionized the endoscope reprocessing industry by standardizing the disinfection process, boosting infection control, and reducing contamination risks. Despite the enhanced efficiency, in-depth research is required to assess the adoption level, cost-effectiveness, and technological advancements in AERs. Detergents & wipes provide critical support to the endoscope reprocessing process, preventing biofilm build-up and ensuring comprehensive disinfection. The impact of factors such as biocompatibility, efficacy, and ease of use on market dynamics needs a thorough examination. Endoscope drying, storage, & transport systems are inherently linked to the reduction in endoscope reprocessing-related infections. Endoscope tracking solutions fortify inventory management, bolster patient safety, and enhance data recording and sharing capabilities. An in-depth assessment of these solutions unearths potential growth sectors, client demands, and technological advancements that will drive future market trends. High-level disinfectants & test strips play a pivotal role in ensuring the sterility of endoscopes.
End-User: Rising adoption of endoscope reprocessing across hospitals with the increasing emphasis on effective infection control and prevention
The ambulatory surgical centers & clinics use endoscope reprocessing with the rising need for cost-effective sterile equipment for patient care, reducing environmental impact and legal compliance for strict hygiene standards. The increasingly complicated design of endoscopes has also necessitated advanced reprocessing solutions for effective sterilization, while the rising patient volume has intensified their need. The end-user group in the hospital setting encompasses a wider range of healthcare providers, considering the diverse departments such as gastroenterology, urology, pulmonology and others where endoscopes are utilized. The group includes physicians, surgeons, endoscopy nurses, anesthesiologists, and institutional housekeeping staff engaged in various stages of endoscope handling, usage, cleaning, and reprocessing. The demand for reprocessed endoscopes in hospitals is significantly driven by patient safety concerns, as hospitals cater to a large volume of patients with diversified diseases and co-morbidities. It is also influenced by the increasing emphasis on effective infection control and prevention, alongside regulatory requirements for maintaining the sterility of medical devices. The growing need for minimally invasive procedures in hospitals has also led to an increase in the use of endoscopes and, consequently, the necessity for their effective reprocessing. In both settings, an encouraging trend is the growing awareness about the relevance and benefits of professionally reprocessed endoscopes.
Regional Insights
The endoscope reprocessing market in the Americas, particularly in North America, demonstrates consistent growth due to the rising prevalence of diseases that require endoscopy procedures, such as gastrointestinal diseases, cancer, and other chronic diseases. The ascending trend of minimally invasive surgeries and technological advancements fuel this growth of the endoscope reprocessing market in the Americas. The evolving healthcare infrastructure across the region and increasing government and non-profit initiatives aimed at promoting early disease detection are driving the demand for endoscopes. However, cost constraints and a lack of skilled personnel could hamper the market's growth to an extent. The EMEA region proves to be a significant player in the endoscope reprocessing market, with Europe leading the realm. Europe's growth is attributed to an aging population, burgeoning demand for endoscope procedures, and a strong technological foundation. On the other hand, the market in the Middle East and Africa currently experiences comparatively slower growth, primarily due to limited access to healthcare and lower technology adoption. Despite this, there exist prospects for growth through potential market untapping and increased investment in healthcare infrastructure.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Endoscope Reprocessing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Endoscope Reprocessing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Endoscope Reprocessing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Advanced Sterilization Products, Inc. by Johnson & Johnson Services, Inc., ARC Group of Companies Inc., ASP Global Manufacturing GmbH, Belimed AG, BES Healthcare Ltd., Borer Chemie AG, CONMED Corporation, Cook Group Incorporated, Ecolab Inc., Getinge AB, Medalkan, Metrex Research, LLC, Micro-Scientific, LLC, NewCura, Olympus Corporation, Ottomed Endoscopy, Richard Wolf GmbH, Schulke & Mayr GmbH, Shinva Medical Instrument Co., Ltd., Steelco S.p.A., STERIS Corporation, Summit Imaging, Inc., Tuttnauer, and Wassenburg Medical B.V..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Endoscope Reprocessing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Endoscope Reprocessing Market?
3. What are the technology trends and regulatory frameworks in the Endoscope Reprocessing Market?
4. What is the market share of the leading vendors in the Endoscope Reprocessing Market?
5. Which modes and strategic moves are suitable for entering the Endoscope Reprocessing Market?